Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 02, 2015
AstraZeneca has announced that its global biologics research and development arm, MedImmune, has entered an agreement granting Daiichi Sankyo Company, Ltd. (Daiichi Sankyo) an exclusive license to develop and commercialize FluMist® Quadrivalent in ...
read more
Wednesday, September 02, 2015
Valeant Pharmaceuticals has announced that its affiliate has entered into a collaboration agreement with AstraZeneca under which Valeant was granted an exclusive license to develop and commercialize brodalumab.
read more
Wednesday, September 02, 2015
Novartis announced that the European Commission has approved Revolade® (eltrombopag) for the treatment of adults with severe aplastic anemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable ...
read more
Wednesday, September 02, 2015
Bristol-Myers Squibb announced that the FDA has accepted for filing and review the supplemental Biologics License Application (sBLA) for Opdivo for the treatment of previously treated patients with non-squamous (NSQ) non-small cell lung cancer (NSCLC...
read more
Wednesday, September 09, 2015
goBalto, Inc. has announced a two-year partnership with the Society for Clinical Research Sites (SCRS), the globe trade organization fully dedicated to representing the interests of clinical research sites.
read more
Wednesday, September 09, 2015
The Ontario Government, University of Toronto, and MaRS Discovery District (MaRS) have announced a collaboration with Janssen Inc. to launch the successful Johnson & Johnson Innovation, JLABS incubator model in Toronto.
read more
Wednesday, September 09, 2015
The United States Pharmacopeial Convention (USP) has announced that Anthony (Tony) Lakavage, J.D., will become Senior Vice President, Global External Affairs, beginning on September 14.
read more
Wednesday, September 09, 2015
SGS Life Science Services, has announced that its facility in Fairfield, NJ, has been upgraded to be Biosafety Level 2 (BSL-2) compliant, according to the Centers for Disease Control and Prevention (CDC) guidelines.
read more
Wednesday, September 09, 2015
Valeant Pharmaceuticals and Progenics Pharmaceuticals have announced that the FDA has accepted for review Valeant's New Drug Application for RELISTOR® (methylnaltrexone bromide) Tablets for the treatment of opioid-induced constipation (OIC) in adult ...
read more
Wednesday, September 09, 2015
The FDA is expanding its alert regarding compounded or repackaged drugs stored in Becton-Dickinson (BD) general use syringes to include certain additional syringe sizes including 1mL, 10mL, 20mL and 30mL BD syringes, and BD oral syringes.
read more
Thursday, September 10, 2015
Pharmaceutical Product Development has announced that Michael Gold, M.D., has joined PPD’s neuroscience team to serve as vice president of global product development, strengthening the company's ability to help biopharmaceutical clients manage the ...
read more
Thursday, September 10, 2015
Frontage, a full service contract research organization (CRO), has announced the appointment of Michael S. Willett, PharmD., RAC as President of its clinical business unit.
read more
Wednesday, September 16, 2015
NVS Influenza Vaccines, now owned and operated by the CSL Limited, announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted to recommend licensure of a candidate ...
read more
Wednesday, September 16, 2015
The FDA is making changes to the requirements for monitoring, prescribing, dispensing, and receiving the schizophrenia medicine clozapine, to address continuing safety concerns and current knowledge about a serious blood condition called severe ...
read more
Wednesday, September 16, 2015
McKesson Corporation and Albertsons announced the signing of a five-year distribution agreement to include the sourcing and distribution of both branded and generic pharmaceuticals, commencing on April 1, 2016.
read more